Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Kang

Showing results (71-80 of 502) with videos related to

Pageof 51
Sort By:
Cell Research|December 3, 2020
Ferroptosis: molecular mechanisms and health implicationsDaolin Tang, Xin Chen, Rui Kang, et al.
Frontiers in Oncology|March 15, 2021
Mitophagy in Pancreatic CancerYangchun Xie, Jiao Liu, Rui Kang, et al.
The Journal of Experimental Medicine|May 12, 2021
Ferroptosis in infection, inflammation, and immunityXin Chen, Rui Kang, Guido Kroemer, et al.
Journal of Intensive Medicine|April 24, 2026
Itaconate modifications: Mechanisms and applicationsYingyi Yang, Rui Kang, Huiting Zhou, et al.
Antioxidants & Redox Signaling|February 2, 2023
The redox protein HMGB1 in cell death and cancerRuochan Chen, Ju Zou, Rui Kang, et al.
Oncoimmunology|May 2, 2022
Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockadeJiao Liu, Rui Kang, Guido Kroemer, et al.
Cancer Gene Therapy|May 3, 2022
The V-ATPases in cancer and cell deathFangquan Chen, Rui Kang, Jiao Liu, et al.
Antioxidants & Redox Signaling|March 31, 2023
The Redox Protein High-Mobility Group Box 1 in Cell Death and CancerRuochan Chen, Ju Zou, Rui Kang, et al.
Nature Reviews. Cancer|November 25, 2025
Targeting macropinocytosis for cancer therapyDaolin Tang, Jiayi Wang, Guido Kroemer, et al.
Oncoimmunology|February 4, 2026
Enhancing immunogenic cell death by targeting the GPX4-ZP3 immune checkpointDaolin Tang, Rui Kang, Peng Liu, et al.
Pageof 51

Showing results (71-80 of 502) with videos related to

Sort By:
Pageof 51
Cell Research|December 3, 2020
Ferroptosis: molecular mechanisms and health implicationsDaolin Tang, Xin Chen, Rui Kang, et al.
Frontiers in Oncology|March 15, 2021
Mitophagy in Pancreatic CancerYangchun Xie, Jiao Liu, Rui Kang, et al.
The Journal of Experimental Medicine|May 12, 2021
Ferroptosis in infection, inflammation, and immunityXin Chen, Rui Kang, Guido Kroemer, et al.
Journal of Intensive Medicine|April 24, 2026
Itaconate modifications: Mechanisms and applicationsYingyi Yang, Rui Kang, Huiting Zhou, et al.
Antioxidants & Redox Signaling|February 2, 2023
The redox protein HMGB1 in cell death and cancerRuochan Chen, Ju Zou, Rui Kang, et al.
Oncoimmunology|May 2, 2022
Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockadeJiao Liu, Rui Kang, Guido Kroemer, et al.
Cancer Gene Therapy|May 3, 2022
The V-ATPases in cancer and cell deathFangquan Chen, Rui Kang, Jiao Liu, et al.
Antioxidants & Redox Signaling|March 31, 2023
The Redox Protein High-Mobility Group Box 1 in Cell Death and CancerRuochan Chen, Ju Zou, Rui Kang, et al.
Nature Reviews. Cancer|November 25, 2025
Targeting macropinocytosis for cancer therapyDaolin Tang, Jiayi Wang, Guido Kroemer, et al.
Oncoimmunology|February 4, 2026
Enhancing immunogenic cell death by targeting the GPX4-ZP3 immune checkpointDaolin Tang, Rui Kang, Peng Liu, et al.
Pageof 51